Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
327.4 INR | +2.06% | +10.39% | +3.44% |
04-04 | Gufic Biosciences Forms New Wholly-Owned Arm in Dubai | MT |
04-03 | Gufic Biosciences Limited Incorporates Wholly Owned Subsidiary Company in Dubai | CI |
Sales 2022 | 7.79B 93.45M 128M | Sales 2023 | 6.91B 82.83M 113M | Capitalization | 18.09B 217M 297M |
---|---|---|---|---|---|
Net income 2022 | 958M 11.49M 15.71M | Net income 2023 | 797M 9.56M 13.07M | EV / Sales 2022 | 3.16 x |
Net Debt 2022 | 528M 6.33M 8.65M | Net Debt 2023 | 3.06B 36.65M 50.11M | EV / Sales 2023 | 3.06 x |
P/E ratio 2022 |
25.2
x | P/E ratio 2023 |
22.7
x | Employees | 1,628 |
Yield 2022 |
0.04% | Yield 2023 |
0.05% | Free-Float | 22.34% |
Latest transcript on Gufic Biosciences Limited
1 day | +2.06% | ||
1 week | +10.39% | ||
Current month | +15.88% | ||
1 month | +14.74% | ||
3 months | -6.07% | ||
6 months | +28.80% | ||
Current year | +3.44% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 41 | 04-06-24 | |
Chief Executive Officer | - | 99-08-30 | |
Director of Finance/CFO | - | 18-10-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 99-08-30 | |
Chief Executive Officer | 41 | 04-06-24 | |
Director/Board Member | 64 | 86-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 327.4 | +2.06% | 135,171 |
24-04-25 | 320.8 | +2.00% | 78,750 |
24-04-24 | 314.4 | -1.93% | 89,409 |
24-04-23 | 320.6 | +7.49% | 386,107 |
24-04-22 | 298.3 | +0.59% | 70,520 |
Delayed Quote NSE India S.E., April 26, 2024 at 07:43 am
More quotes1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- GUFICBIO Stock
- GUFICBIO Stock